Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials

Annals of Oncology - Tập 17 - Trang 1749-1760 - 2006
J. Franklin1, A. Pluetschow1, M. Paus1, L. Specht2, A.-P. Anselmo3, A. Aviles4, G. Biti5, T. Bogatyreva6, G. Bonadonna7, C. Brillant1, E. Cavalieri3, V. Diehl1, H. Eghbali8, C. Fermé9, M. Henry-Amar10, R. Hoppe11, S. Howard12, R. Meyer13, D. Niedzwiecki14, S. Pavlovsky15
1German Hodgkin Study Group, University of Cologne, Germany
2Rigshospitalet, Copenhagen, Denmark
3University of La Sapienza, Rome, Italy
4Oncology Hospital, National Medical Center, Mexico City, Mexico
5University of Florence, Florence, Italy
6Medical Radiological Research Centre, Obninsk, Russia
7Istituto Nationale Tumore, Milan, Italy
8Institut Bergonie, Bordeaux
9Hopital Saint-Louis, Paris
10Centre Regional Francoise Baclesse, Caen, France
11Stanford University School of Medicine, Stanford, CA;
12St Judes Children's Research Hospital, Memphis, TN, USA
13Hamilton Regional Cancer Center, Ontario, Canada
14Duke University School of Medicine, Durham, NC, USA
15FUNDALEU, Buenos Aires, Argentina

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Annals of Oncology

Tập 17

1749-1760

Thông tin tác giả